Consistently, Karim’s study suggested that PD-L1 expression on tumor cells might have no direct influence on survival (58), while patients with both positive PD-L1 expression on tumor cells and infiltrating Tregs might have better survival (62). This evidence concerns the gene CD274 and neoplasm.